Viatris, Inc. (VTRS)
17.39
+1.44
(+9.03%)
USD |
NASDAQ |
May 07, 16:00
17.30
-0.09
(-0.52%)
After-Hours: 05:04
Viatris Research and Development Expense (Annual) : 952.50M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.25B |
| Baxter International, Inc. | 503.00M |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| Dentsply Sirona, Inc. | 150.00M |
| Theravance Biopharma, Inc. | 35.91M |